Literature DB >> 6204384

DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope.

V Enea, J Ellis, F Zavala, D E Arnot, A Asavanich, A Masuda, I Quakyi, R S Nussenzweig.   

Abstract

A clone of complementary DNA encoding the circumsporozoite (CS) protein of the human malaria parasite Plasmodium falciparum has been isolated by screening an Escherichia coli complementary DNA library with a monoclonal antibody to the CS protein. The DNA sequence of the complementary DNA insert encodes a four-amino acid sequence: proline-asparagine-alanine-asparagine, tandemly repeated 23 times. The CS beta-lactamase fusion protein specifically binds monoclonal antibodies to the CS protein and inhibits the binding of these antibodies to native Plasmodium falciparum CS protein. These findings provide a basis for the development of a vaccine against Plasmodium falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204384     DOI: 10.1126/science.6204384

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  57 in total

1.  Primary structure of a proline-rich zein and its cDNA.

Authors:  S Z Wang; A Esen
Journal:  Plant Physiol       Date:  1986-05       Impact factor: 8.340

Review 2.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

3.  An immunodominant site of gamma-zein1 is in the region of tandem hexapeptide repeats.

Authors:  A Esen
Journal:  J Protein Chem       Date:  1990-08

Review 4.  Approaches to malaria vaccine development using the retrospectroscope.

Authors:  Vanessa Sardá; David C Kaslow; Kim C Williamson
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 5.  Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.

Authors:  Jerome P Vanderberg
Journal:  Vaccine       Date:  2008-10-28       Impact factor: 3.641

6.  Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.

Authors:  F A Kironde; K V Rao; S Shah; A Kumar; N Sahoo
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

7.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

8.  Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.

Authors:  A Cheung; J Leban; A R Shaw; B Merkli; J Stocker; C Chizzolini; C Sander; L H Perrin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 9.  Genetically engineered, attenuated whole-cell vaccine approaches for malaria.

Authors:  Ashley M Vaughan; Ruobing Wang; Stefan H I Kappe
Journal:  Hum Vaccin       Date:  2010-01-29

10.  Optimism, persistence, and our collective crystal ball.

Authors:  Thomas E Wellems
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.